Free Trial

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

DENTSPLY SIRONA logo
$19.19 -0.33 (-1.69%)
(As of 05:33 PM ET)

DENTSPLY SIRONA - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
6
Buy
3

Based on 9 Wall Street analysts who have issued ratings for DENTSPLY SIRONA in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 6 have given a hold rating, and 3 have given a buy rating for XRAY.

Consensus Price Target

$29.50
53.73% Upside
According to the 9 analysts' twelve-month price targets for DENTSPLY SIRONA, the average price target is $29.50. The highest price target for XRAY is $42.00, while the lowest price target for XRAY is $24.00. The average price target represents a forecasted upside of 53.73% from the current price of $19.19.
Get the Latest News and Ratings for XRAY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for DENTSPLY SIRONA and its competitors.

Sign Up

XRAY Analyst Ratings Over Time

TypeCurrent Forecast
11/27/23 to 11/26/24
1 Month Ago
10/28/23 to 10/27/24
3 Months Ago
8/29/23 to 8/28/24
1 Year Ago
11/27/22 to 11/27/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
4 Buy rating(s)
Hold
6 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$29.50$32.67$33.44$38.89
Forecasted Upside53.73% Upside40.14% Upside35.24% Upside23.54% Upside
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Moderate Buy

XRAY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XRAY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

DENTSPLY SIRONA Stock vs. The Competition

TypeDENTSPLY SIRONAMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside51.28% Upside17,731.26% Upside6.42% Upside
News Sentiment Rating
Positive News

See Recent XRAY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024Barrington Research
4 of 5 stars
 Lower TargetOutperform ➝ Outperform$36.00 ➝ $24.00+34.53%
11/8/2024Robert W. Baird
2 of 5 stars
 Lower TargetNeutral ➝ Neutral$31.00 ➝ $24.00+39.05%
11/7/2024Leerink Partnrs
5 of 5 stars
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
11/7/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
10/25/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$34.00 ➝ $29.00+23.40%
10/8/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$29.00 ➝ $27.00+11.71%
The Great AI-Energy Collision (Ad)

The biggest players in AI and tech are desperate to bring this limitless power source online. And fast. It’s the only way they can compete in their race for AI dominance. A handful of energy stocks are going to emerge from this transformation to dominate the sector.

Get the full story here, while you still can.
7/18/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$30.00 ➝ $28.00+2.04%
5/6/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$34.00 ➝ $30.00+6.95%
5/3/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$35.00 ➝ $32.00+10.92%
11/10/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Vazquez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
11/3/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$43.00 ➝ $39.00+36.65%
5/5/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$43.00 ➝ $46.00+12.17%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:26 PM ET.


XRAY Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for DENTSPLY SIRONA is $29.50, with a high forecast of $42.00 and a low forecast of $24.00.

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" XRAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.

According to analysts, DENTSPLY SIRONA's stock has a predicted upside of 53.73% based on their 12-month stock forecasts.

Over the previous 90 days, DENTSPLY SIRONA's stock had 2 downgrades by analysts.

DENTSPLY SIRONA has been rated by research analysts at Barrington Research, Evercore ISI, Leerink Partners, Leerink Partnrs, Needham & Company LLC, and Robert W. Baird in the past 90 days.

Analysts like DENTSPLY SIRONA less than other "medical" companies. The consensus rating for DENTSPLY SIRONA is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how XRAY compares to other companies.


This page (NASDAQ:XRAY) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners